1526 - 1550 of 7939 Results
Title
Year
-
RESTRICTEDTitle: The economic imperatives for technology enabled wellness centered healthcareJournal Name: Journal of Public Health PolicyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 3Start Page: 456End Page: 468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1057/s41271-022-00356-8Best OA location URL: https://link.springer.com/content/pdf/10.1057/s41271-022-00356-8.pdfCitation Count: 2
-
OPENTitle: Clinical trajectories and biomarkers for weight variability in early Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00362-3Best OA location URL: https://www.nature.com/articles/s41531-022-00362-3.pdfCitation Count: 13
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://escholarship.org/content/qt8jf94062/qt8jf94062.pdf?t=s0lt8rCitation Count: 8
-
RESTRICTEDTitle: An overview of the active clinical trials for Parkinson’s disease psychosisJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2022-0020Citation Count: 0
- Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis2022RESTRICTEDTitle: Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 119End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.004Citation Count: 12
-
RESTRICTEDTitle: Cellular senescence: a key therapeutic target in aging and diseasesJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 132Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci158450Best OA location URL: http://www.jci.org/articles/view/158450/files/pdfCitation Count: 155
-
RESTRICTEDTitle: Diagnosis and treatment of orthostatic hypotensionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 735End Page: 746Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00169-7Best OA location URL: https://pure.rug.nl/ws/files/234637992/1_s2.0_S1474442222001697_main.pdfCitation Count: 54
-
RESTRICTEDTitle: Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 170Issue #:Start Page: 105744End Page: 105744Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105744Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105744Citation Count: 16
- Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic2022RESTRICTEDTitle: Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinicJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0055Citation Count: 7
-
RESTRICTEDTitle: Isotope tracing in health and diseaseJournal Name: Current Opinion in BiotechnologyPublisher: Elsevier BVVol: 76Issue #:Start Page: 102739End Page: 102739Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.copbio.2022.102739Best OA location URL: https://doi.org/10.1016/j.copbio.2022.102739Citation Count: 13
-
OPENTitle: Late Breaking OralsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 11Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jev2.12252Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12252Citation Count: 0
-
RESTRICTEDTitle: Microbes and Parkinson’s disease: from associations to mechanismsJournal Name: Trends in MicrobiologyPublisher: Elsevier BVVol: 30Issue #: 8Start Page: 749End Page: 760Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.tim.2022.01.004Best OA location URL: http://www.cell.com/article/S0966842X2200004X/pdfCitation Count: 14
-
OPENTitle: Mitochondrial hyperfusion via metabolic sensing of regulatory amino acidsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 40Issue #: 7Start Page: 111198End Page: 111198Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2022.111198Best OA location URL: http://www.cell.com/article/S2211124722010154/pdfCitation Count: 19
-
OPENTitle: Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosisJournal Name: CellPublisher: Elsevier BVVol: 185Issue #: 17Start Page: 3214End Page: 3231.e23Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2022.06.038Best OA location URL: https://doi.org/10.1016/j.cell.2022.06.038Citation Count: 170
-
OPENTitle: Parkinson’s Disease Severity Estimation using Deep Learning and Cloud TechnologyJournal Name: 2022 IEEE International Conference on Omni-layer Intelligent Systems (COINS)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/coins54846.2022.9854945Best OA location URL: https://zenodo.org/record/7020693/files/PD-Severity.pdfCitation Count: 0
-
OPENTitle: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2629End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac281Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2629/45599741/awac281.pdfCitation Count: 0
- PLA2G6-associated neurodegeneration in four different populations-case series and literature review2022RESTRICTEDTitle: PLA2G6-associated neurodegeneration in four different populations-case series and literature reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 66End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.016Best OA location URL: http://manuscript.elsevier.com/S1353802022002115/pdf/S1353802022002115.pdfCitation Count: 4
- Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?2022RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
- Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”2022OPENTitle: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1781End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29131Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756875Citation Count: 0
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022OPENTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: http://manuscript.elsevier.com/S1043661822002833/pdf/S1043661822002833.pdfCitation Count: 7
- The frontostriatal subtype of mild cognitive impairment in Parkinson's disease, but not the posterior cortical one, is associated with specific EEG alterations2022OPENTitle: The frontostriatal subtype of mild cognitive impairment in Parkinson's disease, but not the posterior cortical one, is associated with specific EEG alterationsJournal Name: CortexPublisher: Elsevier BVVol: 153Issue #:Start Page: 166End Page: 177Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cortex.2022.04.015Best OA location URL: http://manuscript.elsevier.com/S0010945222001290/pdf/S0010945222001290.pdfCitation Count: 1
-
RESTRICTEDTitle: What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 79Issue #:Start Page: 101648End Page: 101648Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2022.101648Best OA location URL: https://doi.org/10.1016/j.arr.2022.101648Citation Count: 11
- Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein2022OPENTitle: Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-SynucleinJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 185Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/63313Best OA location URL: https://www.jove.com/pdf/63313/analyzing-parkinson-s-disease-mouse-model-induced-adeno-associatedCitation Count: 0
- Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination2022OPENTitle: Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examinationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00360-5Best OA location URL: https://www.nature.com/articles/s41531-022-00360-5.pdfCitation Count: 3
-
RESTRICTEDTitle: Movement disorders of the mouth: a review of the common phenomenologiesJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 11Start Page: 5812End Page: 5830Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-022-11299-1Citation Count: 5